Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis

被引：0
|
作者：
Poynton, Edward [1 ,2 ]
Chernucha, Emily [3 ]
Day, James [2 ]
Prodger, Catherine [4 ]
Hopkins, David [5 ]
Rakesh, Pallav [5 ,6 ]
O'Neill, Tess [7 ]
Thakrar, Nisha [2 ]
Akarca, Ayse [8 ]
Jamal, Esraa [1 ]
Ali, Ayesha [9 ]
Kirkwood, Amy A. [10 ]
Pomplun, Sabine [8 ]
Marafioti, Teresa [8 ]
Calaminici, Maria
Greaves, Paul [11 ]
Chaganti, Sridhar [6 ]
Mckay, Pam
Smith, Jeffery [12 ]
Eyre, Toby A.
Martinez-Calle, Nicolas [3 ]
Cwynarski, Kate [2 ]
Fox, Christopher P. [13 ]
Okosun, Jessica
机构：
[1] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England
[2] Univ Coll London Hosp, Dept Clin Haematol, London, England
[3] Nottingham Univ Hosp NHS Trust, Nottingham, England
[4] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England
[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[6] Univ Hosp Birmingham NHS Fdn Trust, Ctr Clin Haematol, Birmingham, W Midlands, England
[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haemato Oncol, London, England
[8] Univ Coll London Hosp, Dept Histopathol, London, England
[9] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[10] UCL, Canc Res UK, London, England
[11] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Haematol, London, England
[12] Liverpool Univ Hosp, Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[13] Univ Nottingham, Sch Med, Nottingham, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
PCNSL; primary CNS Lymphoma; double expressor; MYC; BCL2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-184
引用
收藏
页码：S423 / S424
页数：2
相关论文
共 50 条
  • [1] Double-hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report
    Zhang, Yan
    Wang, Wei
    Chen, Tingting
    ONCOLOGY LETTERS, 2023, 25 (04)
  • [2] Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma
    Yoshida, Maki
    Ichikawa, Ayako
    Miyoshi, Hiroaki
    Kiyasu, Junichi
    Kimura, Yoshizo
    Niino, Daisuke
    Ohshima, Koichi
    PATHOLOGY INTERNATIONAL, 2015, 65 (09) : 486 - 489
  • [3] Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements
    Ikoma, Haruka
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Kikuti, Yara Yukie
    Shiraiwa, Sawako
    Hara, Ryujiro
    Kojima, Minoru
    Ohmachi, Ken
    Ando, Kiyoshi
    Carreras, Joaquim
    Nakamura, Naoya
    PATHOLOGY INTERNATIONAL, 2022, 72 (06) : 321 - 331
  • [4] MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: A systematic review and meta-analysis
    Ge, Le
    Lu, Shan
    Xu, Lixia
    Yan, Hua
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 208
  • [5] MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas
    Huang, Wenting
    Medeiros, L. Jeffrey
    Lin, Pei
    Wang, Wei
    Tang, Guilin
    Khoury, Joseph
    Konoplev, Sergej
    Yin, C. Cameron
    Xu, Jie
    Oki, Yasuhiro
    Li, Shaoying
    MODERN PATHOLOGY, 2018, 31 (09) : 1470 - 1478
  • [6] Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma
    Li, Shaoying
    Saksena, Annapurna
    Desai, Parth
    Xu, Jie
    Zuo, Zhuang
    Lin, Pei
    Tang, Guilin
    Yin, C. Cameron
    Seegmiller, Adam
    Jorgensen, Jeffrey L.
    Miranda, Roberto N.
    Reddy, Nishitha M.
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    ONCOTARGET, 2016, 7 (25) : 38122 - 38132
  • [7] Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
    Weiping Li
    Shiv K. Gupta
    Weiguo Han
    Ryan A. Kundson
    Sara Nelson
    Darlene Knutson
    Patricia T. Greipp
    Sherine F. Elsawa
    Eduardo M. Sotomayor
    Mamta Gupta
    Journal of Hematology & Oncology, 12
  • [8] Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
    Huang, Sixia
    Nong, Lin
    Wang, Wei
    Liang, Li
    Zheng, Yalin
    Liu, Jumei
    Li, Dong
    Li, Xin
    Zhang, Bo
    Li, Ting
    DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [9] Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
    Sixia Huang
    Lin Nong
    Wei Wang
    Li Liang
    Yalin Zheng
    Jumei Liu
    Dong Li
    Xin Li
    Bo Zhang
    Ting Li
    Diagnostic Pathology, 14
  • [10] Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
    Li, Weiping
    Gupta, Shiv K.
    Han, Weiguo
    Kundson, Ryan A.
    Nelson, Sara
    Knutson, Darlene
    Greipp, Patricia T.
    Elsawa, Sherine F.
    Sotomayor, Eduardo M.
    Gupta, Mamta
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
12345